Aledade
Aledade provides a cloud-based platform supporting primary care practices in value-based care by integrating data from EHRs and other sources.
Secondary Market Price
How Aledade Measures Up
To help you manage your Aledade equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series F
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Aledade's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Aledade Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Aledade's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Founded in 2014, Aledade operates a large network of independent primary care practices in the United States, focused on value-based care. The company provides a cloud-based platform that integrates with existing electronic health records and practice management systems, consolidating data from sources like hospitals, labs, and claims. Aledade supports its partners with data analytics, personal coaching, and healthcare policy expertise. It currently manages accountable care organizations (ACOs) with over 200 value-based contracts, partnering with more than 2,400 practices and community health centers across 46 states and Washington, D.C., which covers nearly 3 million patients. The company, founded by Farzad Mostashari, MD, has raised $279.9 million in total funding and had revenues of $300 million in fiscal year 2021.
Aledade continues to advocate for policies that support primary care and accountable care models within Medicare, with a focus on physician payment reform. The company is also engaging with new payment structures, such as the Centers for Medicare & Medicaid Services (CMS) Innovation Center's ACCESS Model. In a 2024 update, Aledade reported that its network had prevented 263,000 unnecessary hospitalizations and emergency department visits. In a recent development, one of its partner physicians, Dr. Umar Bowers, was named one of The WilmingtonBiz 100 Innovators by the Greater Wilmington Business Journal. The company's future plans include leveraging technology and AI to improve patient outcomes and expanding its value-based care partnerships.
- Lightspeed Venture Partners
- Venrock
- Fidelity Management & Research Company
- OMERS Growth Equity
- Meritech Capital
- Tiger Global Management
- IVP
- GV
- Co-Founder, Farzad Mostashari
- Co-Founder, Mat Kendall
- Co-Founder, Edwin Miller
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Aledade worth joining?
Deciding to join a company like Aledade involves weighing many factors, including the potential of its equity compensation. Tools like Prospect can help you model the future value of your equity to make a more informed decision.
What should I do with my Aledade stock?
Managing private company stock involves complex decisions around when to exercise options and how to plan for taxes to maximize your take-home value. Prospect offers customized strategies and tax optimization tools to help you make the most of your equity.
Can you sell Aledade stock?
As Aledade is a private company, selling stock is usually possible only during specific liquidity events like tender offers or on secondary markets. Prospect provides tender offer tools to help you decide how much to sell and which shares are the most tax-optimal to offload.
How can I find the value of my Aledade stock?
The value of private stock isn't publicly listed and is often determined by periodic 409A valuations, but its future potential is harder to gauge. You can use Prospect’s predictive models, which are trained on proprietary VC data, to project the future value of your Aledade shares.
What is Aledade's equity worth?
The precise worth of Aledade's equity is not public information and depends on factors like the company's latest valuation and your specific grant details. To understand the potential net value of your personal holdings, you can use a platform like Prospect to model different scenarios and see after-tax projections.
What is Aledade's stock ticker symbol?
Since Aledade is a private company, it does not have a stock ticker symbol and is not traded on public stock exchanges. Ticker symbols are assigned when a company goes public, and tools like Prospect specialize in helping employees manage their equity in the pre-IPO stage.
Can I buy or sell Aledade stock?
Buying stock in a private company like Aledade is generally limited to exercising your employee options, while selling is typically restricted to company-approved liquidity events. Prospect provides tools to help you navigate both exercising options and selling shares in a tax-efficient way.
What is the criteria to buy or invest in Aledade stock?
Investing in a private company like Aledade is typically reserved for institutional investors or employees who have been granted equity compensation. If you are an employee with equity, Prospect can help you manage it, but the platform does not provide a way to purchase shares directly.
